Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order

Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order

VANCOUVER, British Columbia — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp., has signed a Cannabis Products Supplier Agreement with Medical Cannabis by Shoppers Drug Mart Inc. (“Shoppers”).

Related: Pure Extracts Receives Purchase Order for a New Listing of High-Potency Vape Carts from the Ontario Cannabis Store

The initial purchase order (PO) comprises 6 SKUs including Pure Pulls™ THC and CBD full spectrum oil (FSO) vape cartridges, as well as Pure Chews™ THC and CBD edible gummies. The gummies are sold in Pure Extracts’ proprietary blister packages for ultimate freshness and convenience. These products will be made available on the Medical Cannabis by Shoppers™ platform.

Related: Pure Extracts Receives 3 New Listings from the Ontario Cannabis Store

Pure Extracts’ CEO, Ben Nikolaevsky, remarked, “We are excited about joining such a trusted health and wellness retailer as Shoppers and look forward to introducing our brands to their medical customers. This marks another successful milestone in the expansion of our line of branded products and we believe this distribution relationship will contribute a significant amount of revenue to our financials over time.”

About Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.

Find out more at https://pureextractscorp.com/

ON BEHALF OF THE BOARD
Ben Nikolaevsky
Ben Nikolaevsky
CEO and Director

 

This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. Financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from supply agreement recently entered into by the Company, and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.